BTG PLC Notice of Results (2671D)
April 25 2017 - 6:08AM
UK Regulatory
TIDMBTG
RNS Number : 2671D
BTG PLC
25 April 2017
Notice of Results
London, UK, 25 April 2017: BTG plc (LSE: BTG), the global
specialist healthcare company, will announce its preliminary
results for the twelve months ended 31 March 2017 on Tuesday 16 May
2017.
For further information, please contact:
BTG
Andy Burrows, VP Corporate & Investor Relations
+44 (0)20 7575 1741; Mobile: +44 (0)7990 530 605
Stuart Hunt, Investor Relations Manager
+44 (0)20 7575 1582; Mobile: +44 (0)7815 778 536
Chris Sampson, Corporate Communications Director
+44 (0)20 7575 1595; Mobile: +44 (0)7773 251 178
FTI Consulting
Ben Atwell / Simon Conway
+44 (0)20 3727 1000
About BTG
BTG is a growing international specialist healthcare company
bringing to market innovative products in specialist areas of
medicine to better serve doctors and their patients. We have a
portfolio of Interventional Medicine products to advance the
treatment of liver tumours, severe blood clots, varicose veins and
advanced emphysema, and Specialty Pharmaceuticals that help
patients overexposed to certain medications or toxins. Inspired by
patient and physician needs, BTG is investing to expand its
portfolio to address some of today's most complex healthcare
challenges. To learn more about BTG, please visit:
www.btgplc.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORLLFILSRIEFID
(END) Dow Jones Newswires
April 25, 2017 07:08 ET (11:08 GMT)
Btg (LSE:BTG)
Historical Stock Chart
From Apr 2024 to May 2024
Btg (LSE:BTG)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Btg Plc (London Stock Exchange): 0 recent articles
More BTG News Articles